BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Intestine
,
Amniocentesis
,
Doxorubicin
,
rs7903146
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cholinesterases
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Primary hepatocytes treated with VX (O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothioate)
HepG2 cells treated with genotoxic and non-genotoxic agents
Embryonal carcinoma NT2 cells neuronally differentiated in the presence of paraoxon or mipafox
Expression data from human Jurkat T cells exposed to 31 compounds
Brain gene expression following exposure to the oganophosphonate anti-cholinesterase Sarin
Explore Curated Studies Results
Literature
Most Relevant Literature
Research on cholinesterases in the Soviet Union and Russia: a historical perspective.
The progress in the cholinesterase quantification methods.
Thioesters for the in vitro evaluation of agents to image brain cholinesterases.
To the 80-anniversary of cholinesterase. The cholinesterase club in Sechenov Institute of Evolutiona…
Cholinesterase-responsive supramolecular vesicle.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cholinesterase Inhibitor Discontinuation
Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)
Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease
Point of Care Testing of Cholinesterase Activity During Burn- and Polytrauma
Estimation of Functional Liver Reserve Using Cholinesterases
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ